Healthcare provider profile · identity verified

Joseph W Prows, MD

Family Practice · FORT COLLINS, CO · NPI 1417183070

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	423	122
Rosuvastatin Calcium	Rosuvastatin Calcium	352	107
Amlodipine Besylate	Amlodipine Besylate	283	71
Levothyroxine Sodium	Levothyroxine Sodium	271	63
Lisinopril	Lisinopril	216	63
Gabapentin	Gabapentin	193	47
Tamsulosin Hcl	Tamsulosin Hcl	188	57
Omeprazole	Omeprazole	141	50
Losartan Potassium	Losartan Potassium	135	35
Trazodone Hcl	Trazodone Hcl	120	38
Pantoprazole Sodium	Pantoprazole Sodium	104	27
Metoprolol Succinate	Metoprolol Succinate	98	28
Finasteride	Finasteride	91	25
Metformin Hcl	Metformin Hcl	83	24
Oxycodone Hcl	Oxycodone Hcl	83	11
Hydrochlorothiazide	Hydrochlorothiazide	79	24
Mirtazapine	Mirtazapine	77	19
Alendronate Sodium	Alendronate Sodium	69	23
Ozempic	Semaglutide	67	13
Sertraline Hcl	Sertraline Hcl	67	16
Albuterol Sulfate Hfa	Albuterol Sulfate	64	26
Furosemide	Furosemide	63	22
Allopurinol	Allopurinol	61	19
Duloxetine Hcl	Duloxetine Hcl	56	15
Venlafaxine Hcl Er	Venlafaxine Hcl	56	11
Eliquis	Apixaban	52	18
Zolpidem Tartrate	Zolpidem Tartrate	52	17
Glipizide	Glipizide	50	14
Metoprolol Tartrate	Metoprolol Tartrate	48	15
Carvedilol	Carvedilol	47	suppressed
Alprazolam	Alprazolam	46	12
Potassium Chloride	Potassium Chloride	45	16
Bupropion Xl	Bupropion Hcl	44	11
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	44	14
Montelukast Sodium	Montelukast Sodium	43	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	42	17
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	40	suppressed
Fluticasone Propionate	Fluticasone Propionate	38	15
Lorazepam	Lorazepam	38	15
Prednisone	Prednisone	38	28
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	36	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	35	suppressed
Jardiance	Empagliflozin	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	35	18
Escitalopram Oxalate	Escitalopram Oxalate	34	12
Simvastatin	Simvastatin	33	suppressed
Testosterone Cypionate	Testosterone Cypionate	33	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	32	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Citalopram Hbr	Citalopram Hydrobromide	30	11
Clonazepam	Clonazepam	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Morphine Sulfate Er	Morphine Sulfate	29	suppressed
Pravastatin Sodium	Pravastatin Sodium	29	suppressed
Chlorthalidone	Chlorthalidone	28	suppressed
Estradiol	Estradiol	27	11
Metformin Hcl Er	Metformin Hcl	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Aripiprazole	Aripiprazole	26	suppressed
Zubsolv	Buprenorphine Hcl/Naloxone Hcl	26	suppressed
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Mounjaro	Tirzepatide	24	suppressed
Warfarin Sodium	Warfarin Sodium	24	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Olanzapine	Olanzapine	23	suppressed
Spironolactone	Spironolactone	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Diazepam	Diazepam	22	suppressed
Ondansetron Odt	Ondansetron	22	suppressed
Tramadol Hcl	Tramadol Hcl	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	12
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Divalproex Sodium	Divalproex Sodium	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Linzess	Linaclotide	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Valsartan	Valsartan	15	suppressed
Buprenorphine	Buprenorphine	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Pitavastatin Calcium	Pitavastatin Calcium	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Testosterone	Testosterone	14	suppressed
Vraylar	Cariprazine Hcl	14	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	11
Baclofen	Baclofen	13	suppressed
Carbamazepine Er	Carbamazepine	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	13	suppressed
Dutasteride	Dutasteride	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Naltrexone Hcl	Naltrexone Hcl	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	12	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error